119 related articles for article (PubMed ID: 1318947)
21. Regulation of gene expression directed by the long terminal repeats of feline leukemia viruses.
Nishigaki K; Endo Y; Matsumoto Y; Watari T; Goitsuka R; Tsujimoto H; Hasegata A
Leukemia; 1997 Apr; 11 Suppl 3():189-92. PubMed ID: 9209339
[TBL] [Abstract][Full Text] [Related]
22. The genome of feline immunodeficiency virus.
Miyazawa T; Tomonaga K; Kawaguchi Y; Mikami T
Arch Virol; 1994; 134(3-4):221-34. PubMed ID: 8129613
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the vif gene of feline immunodeficiency virus.
Shacklett BL; Luciw PA
Virology; 1994 Nov; 204(2):860-7. PubMed ID: 7941360
[TBL] [Abstract][Full Text] [Related]
24. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus.
Sparger EE; Beebe AM; Dua N; Himathongkam S; Elder JH; Torten M; Higgins J
Virology; 1994 Dec; 205(2):546-53. PubMed ID: 7975256
[TBL] [Abstract][Full Text] [Related]
25. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
[TBL] [Abstract][Full Text] [Related]
26. Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication.
de Parseval A; Ngo S; Sun P; Elder JH
J Virol; 2004 Sep; 78(17):9132-43. PubMed ID: 15308709
[TBL] [Abstract][Full Text] [Related]
27. Regulatory properties of the integrated long terminal repeat of the feline immunodeficiency virus.
Ikeda Y; Kawaguchi Y; Tomonaga K; Inoshima Y; Kohmoto M; Miyazawa T; Mikami T
Virus Res; 1996 Apr; 41(2):201-7. PubMed ID: 8738180
[TBL] [Abstract][Full Text] [Related]
28. Expression of feline immunodeficiency virus Vif is associated with reduced viral mutation rates without restoration of replication of vif mutant viruses.
Paul TA; Casey JW; Avery RJ; Sutton CA
Virology; 2007 Apr; 361(1):112-22. PubMed ID: 17169394
[TBL] [Abstract][Full Text] [Related]
29. Activation of feline immunodeficiency virus long terminal repeat by feline herpesvirus type 1.
Kawaguchi Y; Miyazawa T; Horimoto T; Itagaki S; Fukasawa M; Takahashi E; Mikami T
Virology; 1991 Sep; 184(1):449-54. PubMed ID: 1651603
[TBL] [Abstract][Full Text] [Related]
30. Growth properties of a feline immunodeficiency virus mutant which lacks an AP-1 binding site in primary peripheral blood mononuclear cells.
Miyazawa T; Inoshima Y; Kohmoto M; Ikeda Y; Mikami T
J Vet Med Sci; 1994 Oct; 56(5):869-72. PubMed ID: 7532437
[TBL] [Abstract][Full Text] [Related]
31. Investigation into the mode of action of R-91650, an arylpiperazinyl fluoroquinolone, on feline immunodeficiency virus replication inhibitory activity.
Kashiwase H; Katsube T; Iida K; Komai T; Nishigaki T; Kimura T; Yamashita M
Arch Virol; 2000; 145(5):859-69. PubMed ID: 10881674
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the replication of feline immunodeficiency virus by lentiviral vector-mediated RNA interference in feline cell lines.
Baba K; Goto-Koshino Y; Mizukoshi F; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2008 Aug; 70(8):777-83. PubMed ID: 18772551
[TBL] [Abstract][Full Text] [Related]
33. The effects of Avemar treatment on feline immunodeficiency virus infected cell cultures.
Tarcsai KR; Hidvégi M; Corolciuc O; Nagy K; Abbas AA; Ablashi DV; Kövesdi V; Ongrádi J
Vet Med Sci; 2023 Jul; 9(4):1446-1455. PubMed ID: 37079719
[TBL] [Abstract][Full Text] [Related]
34. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.
de Parseval A; Elder JH
J Virol; 2001 May; 75(10):4528-39. PubMed ID: 11312323
[TBL] [Abstract][Full Text] [Related]
35. Replication properties of clade A/C chimeric feline immunodeficiency viruses and evaluation of infection kinetics in the domestic cat.
de Rozìeres S; Thompson J; Sundstrom M; Gruber J; Stump DS; de Parseval AP; VandeWoude S; Elder JH
J Virol; 2008 Aug; 82(16):7953-63. PubMed ID: 18550665
[TBL] [Abstract][Full Text] [Related]
36. CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells.
Poeschla EM; Looney DJ
J Virol; 1998 Aug; 72(8):6858-66. PubMed ID: 9658135
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the Rev transactivation of feline immunodeficiency virus in feline and non-feline cell lines.
Tomonaga K; Miyazawa T; Kawaguchi Y; Kohmoto M; Inoshima Y; Mikami T
J Vet Med Sci; 1994 Feb; 56(1):199-201. PubMed ID: 8204756
[TBL] [Abstract][Full Text] [Related]
38. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
Uncini Manganelli RE; Zaccaro L; Tomei PE
J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
[TBL] [Abstract][Full Text] [Related]
39. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro.
Hohdatsu T; Sasagawa T; Yamazaki A; Motokawa K; Kusuhara H; Kaneshima T; Koyama H
Arch Virol; 2002 Aug; 147(8):1517-29. PubMed ID: 12181672
[TBL] [Abstract][Full Text] [Related]
40. TNF-alpha-induced cell death in feline immunodeficiency virus-infected cells is mediated by the caspase cascade.
Mizuno T; Goto Y; Baba K; Masuda K; Ohno K; Tsujimoto H
Virology; 2001 Sep; 287(2):446-55. PubMed ID: 11531421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
